Search results
Aug 10, 2022 · Who owns Haleon shares? There are a number of significant shareholders of Haleon, according to Keith Bowman, senior equity analyst at interactive investor. “US drugs company Pfizer remains Haleon’s biggest shareholder at around 32%, having held an interest in GSK before Haleon’s recent demerger,” he said.
- Rob Griffin
- 237, 28th October Street, Limassol, Cyprus, 3035
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.
May 17, 2024 · GSK has sold its remaining stake in Haleon, the consumer healthcare company it spun off and listed in London in July 2022, raising £1.25bn and underscoring how pharmaceutical groups are ...
Jul 18, 2022 · It is expected that American Depositary Shares representing shares of Haleon plc (ticker: “NYSE: HLN”) (“Haleon ADSs”) will commence “regular-way” trading on the New York Stock Exchange (the “NYSE”) at market open on Friday 22 July 2022.
Jun 1, 2022 · The Demerger completed on Monday 18 July 2022 and GSK shareholders received one Haleon plc share for each GSK plc share held at 6.00pm UK on Friday 15 July 2022. If you were a GSK shareholder at that time you are now a shareholder in both GSK and Haleon.
Jul 18, 2022 · Haleon, the consumer healthcare company behind brands such as Sensodyne and Aquafresh toothpaste, Centrum vitamins, Voltaren, Panadol and Advil painkillers, Tums heartburn tablets and Nicorette smoking cessation products, was valued at £31bn when it took its stock market bow on Monday morning.
Jul 22, 2022 · GlaxoSmithKline (GSK) has demerged from its consumer healthcare division and a new company, Haleon (HLN) will now be the home of leading brands such as Sensodyne toothpaste and Advil painkillers.
